3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Nasopharyngeal Carcinoma
4
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Sarcoma, Ewing
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Locally Advanced Resectable Rectal Cancer
1
Leukemia, Biphenotypic, Acute
1
Gastric Cancer With Liver Metastases
1
Endometrial Neoplasms
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Interventions
pembrolizumab
14
Cisplatin
8
Carboplatin
4
dostarlimab
3
Cetuximab
3
abemaciclib
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Fulvestrant
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
tislelizumab
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
nimotuzumab
1
merphos
1
ibrutinib
1
fludarabine
1
exemestane
1
entrectinib
1
carbohydrate-deficient transferrin
1
brodalumab
1
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Drug Therapy
×
30 days
×
Clear all
No trials found.